Hyperlipidemic Potential of Polyherbal Siddha Formulation D5 Chooranam

Articles

Abstract
Pharmacognosy Research,2024,16,2,376-383.
Published:April 2024
Type:Original Article
Authors:
Author(s) affiliations:

Gaddam Dayanand Reddy1,*, Rethinam Ganesan2, Manikantavinay Jayavaram1, Venkata Narasimhakumar G3, Bhavani Krishnamoorthy1, Shahana Ahamed1

1Department of Pharmacology, Siddha Central Research Institute, Chennai, Tamil Nadu, INDIA.

2Department of Biochemistry, Siddha Central Research Institute, Chennai, Tamil Nadu, INDIA.

3Department of Pharmacology, Dr. Anjali Chatterjee Regional Research Institute for Homeopathy, Kolkata, West Bengal, INDIA.

Abstract:

Background: Hyperlipidemia is an important public health problem with increasing incidence and prevalence worldwide. D5 Chooranam is a synergetic Siddha polyherbal formulation designed by Central Council for Research in Siddha which is under patent process. Materials and Methods: In this study assessment of antihyperlipidemic activity of D5 Chooranam was carried out using high fat diet-induced hyperlipidemic model. After 8 weeks of induction hyperlipidemia, the male Wistar rats were treated orally with 250 mg/kg, 500 mg/kg and 750 mg/kg of D5 Chooranam for 6 weeks. Results: The results demonstrated significant hypolipidemic activity by lowering total cholesterol, Low Density Lipoprotein (LDL), Very Low-Density Lipoprotein (VLDL), and triglycerides and by increasing HDL levels compared to hyperlipidemic rats. Atorvastatin (10 mg/kg) was used as a positive control. The reduced AST and ALT levels showed its protective role against hepatic damage. Histopathological findings in rat liver supported the protective role of D5 Chooranam in HFD-induced fatty liver. No significant changes in the renal and cardiac markers provide evidence that D5 Chooranam may not possess serious side effects. Conclusion: Therefore, the study suggests that D5 Chooranam could be effective in treating hyperlipidemia.

PDF
Current View
Click here to download the PDF file.
Images

Effect of D5 Chooranam on serum creatinine levels of the HFD fed animals after 6 weeks of treatment.

Keywords

Cite This Article